Simplex Trading’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,250
| Closed | -$221K | – | 11120 |
|
|
2022
Q3 | $221K | Buy |
+3,250
| New | +$179K | ﹤0.01% | 4483 |
|
|
2022
Q2 | – | Sell |
-10,714
| Closed | -$314K | – | 11619 |
|
|
2022
Q1 | $371K | Buy |
+10,714
| New | +$320K | ﹤0.01% | 4254 |
|
|
2021
Q4 | – | Sell |
-32,897
| Closed | -$1.02M | – | 11832 |
|
|
2021
Q3 | $1.23M | Buy |
32,897
+2,200
| +7% | +$64.7K | ﹤0.01% | 2790 |
|
|
2021
Q2 | $1.07M | Buy |
30,697
+21,574
| +236% | +$842K | ﹤0.01% | 3004 |
|
|
2021
Q1 | $371K | Sell |
9,123
-49,137
| -84% | -$2.26M | ﹤0.01% | 3833 |
|
|
2020
Q4 | $2.52M | Buy |
+58,260
| New | +$2.87M | ﹤0.01% | 1534 |
|
|
2020
Q2 | – | Sell |
-2,195
| Closed | -$151K | – | 8643 |
|
|
2020
Q1 | $112K | Buy |
+2,195
| New | +$147K | ﹤0.01% | 4257 |
|
|
2019
Q3 | – | Sell |
-17,467
| Closed | -$910K | – | 8120 |
|
|
2019
Q2 | $918K | Buy |
17,467
+10,062
| +136% | +$578K | ﹤0.01% | 1982 |
|
|
2019
Q1 | $391K | Sell |
7,405
-5,599
| -43% | -$275K | ﹤0.01% | 2913 |
|
|
2018
Q4 | $533K | Buy |
13,004
+2,986
| +30% | +$112K | ﹤0.01% | 2164 |
|
|
2018
Q3 | $380K | Buy |
+10,018
| New | +$444K | ﹤0.01% | 2913 |
|
|
2018
Q2 | – | Sell |
-13,635
| Closed | -$621K | – | 8071 |
|
|
2018
Q1 | $658K | Buy |
+13,635
| New | +$761K | 0.03% | 574 |
|
|
2017
Q3 | – | Sell |
-3,239
| Closed | -$91.1K | – | 6885 |
|
|
2017
Q2 | $88K | Buy |
+3,239
| New | +$96.4K | ﹤0.01% | 1867 |
|
|
2017
Q1 | – | Sell |
-4,131
| Closed | -$104K | – | 7006 |
|
|
2016
Q4 | $59K | Buy |
+4,131
| New | +$72.6K | ﹤0.01% | 1998 |
|
|
2016
Q3 | – | Sell |
-5,974
| Closed | -$114K | – | 6684 |
|
|
2016
Q2 | $99K | Buy |
5,974
+2,330
| +64% | +$47K | 0.01% | 1474 |
|
|
2016
Q1 | $57K | Buy |
+3,644
| New | +$64.7K | ﹤0.01% | 1859 |
|
Other funds holding GBT
Simplex Trading's GBT Position: Q4 2022 in Review
Simplex Trading sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 3,250 shares — an estimated $221K sold.
Simplex Trading first reported a position in GBT in Q1 2016 and held it in 16 quarters. The position peaked at $2.52M in Q4 2020. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.
- Simplex Trading reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
- Simplex Trading sold 3,250 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $221K.
- Simplex Trading first reported a position in Global Blood Therapeutics, Inc. in Q1 2016 and held it in 16 quarters.
- Simplex Trading's Global Blood Therapeutics, Inc. position peaked at $2.52M in Q4 2020.
- 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.
Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.